http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9721438-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68b5b238aba23c160783eb27e6e3e640 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 |
| filingDate | 1996-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecc7dd902183231fa62ae414d6ec417 |
| publicationDate | 1997-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9721438-A1 |
| titleOfInvention | Method for controlling serum glucose, fatty acids, and blood pressure in non-insulin-dependent diabetic mellitus patients |
| abstract | The present invention is a method of treating non-insulin-dependent diabetes mellitus comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of general formula (I) for a period of time of more than 6 days, wherein Y is O; R is OH, NHCONR4R5, or N=C(NR4R5)2; R?4 and R5¿ are each independently selected from the group consisting of hydrogen; C¿1-10? alkyl, straight or branched chain; aryl C1-4 alkyl; and mono- or disubstituted aryl C1-4 alkyl where the substituents are fluoro, chloro, bromo, iodo or C1-10 alkyl, straight or branched chain; R?1 and R2¿ are each independently selected from the group consisting of hydrogen, amino, and mono- or di-substituted chain C¿3-8?, cycloalkyl; provided that R?1 and R2¿ may not both be amino or substituted amino; and R3 is hydrogen, trifluoromethyl, fluoro, chloro, bromo, or iodo; or a pharmaceutically acceptable salt thereof. |
| priorityDate | 1995-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 277.